Graham Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Graham Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$436K	Buy
2025 Q2	$368K	Sell
2025 Q1	$1.64M	Buy
2024 Q4	$1.13M	Buy
2024 Q2	–	Sell
2024 Q1	$430K	Buy
2023 Q4	$292K	Buy
2022 Q2	–	Sell
2022 Q1	$420K	Buy